NOTICE: Due to a lapse in annual appropriations, most of this website is not being updated. Learn more.

Form submissions will still be accepted but will not receive responses at this time. Sections of this site for programs using non-appropriated funds (such as NVLAP) or those that are excepted from the shutdown (such as CHIPS and NVD) will continue to be updated.

U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

PUBLICATIONS

Strategies for Achieving Measurement Assurance for Cell Therapy Products

Published

Author(s)

Carl G. Simon Jr., Anne L. Plant, Sumona Sarkar, John T. Elliott, Sheng Lin-Gibson

Abstract

Cell therapy products (CTPs) need quantitative, validated, and robust assays to support informed decision making during their development, manufacturing, and regulation. These products, the materials involved in their production and the methods for characterizing them are complex, making it challenging to validate and standardize measurements for this field. A workshop held at the National Institute of Standards and Technology examined measurement assurance strategies for cell therapy products.
Citation
Science
Volume
5
Pub Type
Journals

Keywords

stem cells, biomanufacturing, regenerative medicine, tissue engineering, measurement assruance
Bioscience, Health, Biomanufacturing and Standards

Citation

Simon, C. , Plant, A. , Sarkar, S. , Elliott, J. and Lin-Gibson, S. (2016), Strategies for Achieving Measurement Assurance for Cell Therapy Products, Science (Accessed October 14, 2025)

Issues

If you have any questions about this publication or are having problems accessing it, please contact [email protected].

Created June 1, 2016, Updated February 19, 2017
Was this page helpful?